Sale!

Replica Osimertinib: Targeted EGFRm NSCLC Therapy

Original price was: $575.00.Current price is: $416.00.

Third-generation EGFR-TKI, Irreversible inhibitor, Targets EGFR Ex19Del, EGFR L858R mutations, Cerebral metastasis activity,

SKU: SKU67E58ZE2U Category:
Guaranteed Safe Checkout

Third-generation EGFR-TKI, Irreversible inhibitor, Targets EGFR Ex19Del, EGFR L858R mutations, Cerebral metastasis activity,

Reviews

There are no reviews yet.

Be the first to review “Replica Osimertinib: Targeted EGFRm NSCLC Therapy”

Your email address will not be published. Required fields are marked *

Scroll to Top